Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Cognitive Training for Mood and Anxiety Disorders [NA]
Completed clinical trial evaluating cognitive training for mood and anxiety disorders, sponsored by Icahn School of Medicine at Mount Sinai.
-
CLINICAL_TRIALS research · 2017-07-21Clinical Trial Update: A Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy Subjects [Phase 1]
A Phase 1 study evaluating single doses of Lamotrigine and Vofopitant, alone and in combination, on resting motor threshold in healthy subje…
-
EMA safety_alert · 2017-07-11EMA seeks views of public during its safety review of valproate
EMA is seeking public input as part of its safety review of valproate, focusing on potential risks and safer use to protect patients, partic…
-
FDA approval · 2017-07-03FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for quetiapine fumarate filed by Unichem Pharmaceuticals (USA), Inc.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Examination of Tamoxifen in Acute Mania in Patients With Bipolar I Disorder [Phase 2]
Phase 2 clinical trial evaluating tamoxifen for acute mania in Bipolar I Disorder has completed, with the document providing the trial statu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Clinical Trial of Mifepristone for Bipolar Depression [Phase 2]
This update reports on a Phase 2 clinical trial evaluating mifepristone for bipolar depression sponsored by the National Institute of Mental…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Brain Imaging in Depression
A brain imaging clinical trial sponsored by the National Institute of Mental Health has completed, studying participants with depression and…
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Perspectives of Individuals With Bipolar Disorder and Siblings of Individuals With Bipolar Disorder; A Telephone Interview Study
A completed telephone interview study exploring perspectives of individuals with bipolar disorder and their siblings.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Dopamine Receptor Imaging in Mood Disorders
The NIMH-sponsored clinical trial evaluating dopamine receptor imaging in mood disorders has completed, with conditions including major depr…
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: A Glutamate Transporter GLT1, in the Treatment of Bipolar Disorder [Phase 2]
Phase 2 trial investigating a glutamate transporter GLT1 for bipolar disorder was withdrawn.
-
FDA approval · 2017-06-30FDA Approved: QUETIAPINE — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for quetiapine from Accord Healthcare Inc. (ANDA 202152).
-
FDA approval · 2017-06-30FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for quetiapine fumarate (Quetiapine) by BluePoint Laboratories under an existing ANDA. This represen…
-
FDA approval · 2017-06-30FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for a generic quetiapine fumarate by Alembic Pharmaceuticals Limited.
-
FDA approval · 2017-06-30FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Macleods Pharmaceuticals Limited to market quetiapine fumarate. The approval covers a generic ve…
-
CLINICAL_TRIALS trial_result · 2017-06-29Clinical Trial Update: Staccato Loxapine in Agitated Patients With Bipolar Disorder [Phase 3]
Phase 3 clinical trial of Staccato Loxapine for agitation in Bipolar I Disorder has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Multiple Treatment Study Using Low Field Magnetic Stimulation for Bipolar Depression [NA]
A completed clinical trial investigating low field magnetic stimulation for bipolar depression; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-06-23Clinical Trial Update: Psychosocial Intervention to Reduce Self-stigma and Improve Quality of Life Among People With Mental Illness in Chile [NA]
The University of Chile conducted a completed clinical trial evaluating a psychosocial intervention to reduce self-stigma and improve qualit…
-
FDA label_change · 2017-06-22FDA Approved: QUETIAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's supplemental application for quetiapine (generic), updating the drug's labeling under the approved ANDA.
-
FDA approval · 2017-06-22FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for quetiapine fumarate by Hikma Pharmaceuticals USA Inc., representing a new or updated approval fo…
-
CLINICAL_TRIALS research · 2017-06-20Clinical Trial Update: Financial Incentives to Improve Acceptance of Antipsychotic Injections [NA]
This clinical trial update explores using financial incentives to improve acceptance of antipsychotic injections in patients with schizophre…
-
CLINICAL_TRIALS research · 2017-06-20Clinical Trial Update: Study of Predictor of Mood Relapse in Bipolar Disorders [NA]
A clinical trial update from Assistance Publique - Hôpitaux de Paris describing a study that aims to identify predictors of mood relapse in …
-
FDA approval · 2017-06-16FDA Approved: LAMOTRIGINE KIT — Supplemental Application (OWP Pharmaceuticals, Inc.)
FDA approved a supplemental application for Lamotrigine Kit from OWP Pharmaceuticals, Inc., enabling its marketing as a lamotrigine-based pr…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Event Marker Ingested To Trigger Event Recorder 3.0 Psychiatry Study [NA]
Proteus Digital Health completed a psychiatry trial using the Event Marker ingestible sensor to trigger an event recorder in patients with b…
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Bipolar Depression [NA]
Clinical trial update on repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant bipolar depression; study completed wit…
-
CLINICAL_TRIALS trial_result · 2017-06-07Clinical Trial Update: Evaluation of QTc Interval by Continuous Holter ECG Recording in Antipsychotic Drug-treated Patients With Schizophrenia [NA]
A completed clinical trial evaluated QTc interval changes using continuous Holter ECG in patients treated with antipsychotic drugs for schiz…